1. Introduction {#sec1}
===============

Endothelial cells maintain vascular homeostasis through inhibiting platelet aggregation, preventing adhesion of leukocytes, and limiting proliferation of vascular smooth muscle and through balancing vasodilators and vasoconstrictors to manipulate vascular tone. Endothelial dysfunction is reported to be the initial step of many cardiovascular pathophysiological progresses, such as hypertension \[[@B1]\], coronary artery disease \[[@B2]\], or heart failure \[[@B3]\]. Meanwhile, clinical intervention to reserve or augment the endothelium function is recommended to be an appropriated method to CVD treatments. The latest studies show that oxidative stress plays a main character in the pathogenesis of endothelial dysfunction \[[@B4]\], and oxidative stress induces apoptosis \[[@B5]\].

Polydatin, 3,4′,5-trihydroxystilbene-3-*β*-mono-d-glucoside, is extracted from the root stem of a traditional Chinese herbal medicine named*Polygonum cuspidatum*Sieb. A large number of evidences show that PD is involved in a wide range of biological functions, such as antiplatelet aggregation \[[@B6]\] and antiatherosclerosis \[[@B7]\]. It has been demonstrated that PD acts as antioxidant agents to prevent severe diseases. Particularly the PD induced antioxidative activity is reported to reverse renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic \[[@B8]\]. Besides, PD could eliminate ischemia reperfusion (I/R) damage toward brain \[[@B9]\] and lung \[[@B10]\], in which the antioxidative stress ability was thought to be one of the key regulators. PD is proved to exert inhibitory effects on I/R-induced apoptosis in myocardium \[[@B11]\]. Resveratrol (RSV), the deglycosylation form of (PD), could mitigate oxidative stress-induced apoptosis in C2C12 cells and primary neonatal rat cardiomyocytes \[[@B12]\] and increase viability of dopaminergic neurons against neurotoxicity \[[@B13]\]. PKCs are involved in the effects of PD on cardiac ischemia \[[@B14]\] and hypoxic pulmonary hypertension \[[@B15]\]. However, whether PKC cellular circuit is involved in the prevention by PD from H~2~O~2~-induced OSI has not been elucidated to date.

The Protein Kinase C (PKC) is a group of serine/threonine kinases and important intracellular signal transduction molecules. It possesses multiple functions in regulating cellular differentiation \[[@B16]\], proliferation \[[@B17]\], and apoptosis \[[@B18]\]. PKCs are particularly important in redox reaction because their regions are susceptible to redox modifications, since variations of redox state have consequences on their activity \[[@B19]\]. According to the N-terminal regulatory domains, PKCs are classified into three subfamilies: conventional (*α*, *β*I, *β*II, and *γ*), novel (*δ*, *ε*, *η*, *θ*, and *μ*), and atypical (*ζ* and *λ*). The expression of PKCs in cardiac tissue differs with species and cell type, but most adult mammals express PKC *α*, *β*, *δ*, and *ε* \[[@B20]\]. PKC *α*, the first found conventional PKC, is expressed at a high level in cardiovascular system and is activated in cardiomyocytes subjected to oxidative stress \[[@B21]\]. PKC *δ* is the representative of novel PKC and is widely involved in oxidative stress events \[[@B22]\]. Although PKCs *δ* and *ε* are highly homologous, PKC *ε* is known for its antioxidative ability \[[@B23]\] and cardioprotection in the I/R model \[[@B24]\] which differs from the function of PKC *δ*.

In this study, we investigated the role of PD in H~2~O~2~-induced OSI of HUVECs. Then we explored whether PD protected HUVECs against OSI injury via regulation of PKC signaling pathway. Furthermore the possible involvement of PKCs *α*, *δ*, and *ε*, the representative and unique isoforms, was demonstrated in PD treatment of the oxidative stress injured HUVECs.

2. Materials and Methods {#sec2}
========================

2.1. Chemicals and Reagents {#sec2.1}
---------------------------

The PD was purchased from WeiJia Technology Company (Xi\'an, China), and MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\], PKC pathway activator thymeleatoxin (THX), and 2′,7′-dichlorofluorescein diacetate (2′,7′-DCFH-DA) were purchased from Sigma-Aldrich Company (St. Louis, MO, USA). Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) kits were purchased from Roche Company (Mannheim, Germany). The kits for the detection of LDH, GSH-Px, and SOD concentrations and caspase-3 activity were purchased from the Institute of Jiancheng Bioengineering (Nanjing, Jiangsu, China). The PKC *α*, PKC *δ*, PKC *ε*, Bcl-2, Bax, and GAPDH antibodies were purchased from Bioss (Beijing, China). The p-PKC *α*/*β* (Thr638/641) and p-PKC *δ* (Tyr311) antibodies were purchased from Proteintech Group (Chicago, USA) and the p-PKC *ε* (Ser729) antibody was purchased from Sigma-Aldrich Company (St. Louis, MO, USA). The secondary antibodies (goat anti-rabbit and anti-mouse) were purchased from Zhongshan Company (Beijing, China).

2.2. Cell Culture and Treatments {#sec2.2}
--------------------------------

HUVECs (ATCC CRL-1730; Shanghai Tiancheng Technology Company) were cultured in RPMI 1640 medium (Hyclone, Utah, USA) containing heat-inactivated 10% fetal bovine serum, 100 U/mL penicillin, and 100 *μ*g/mL (100 U/mL) streptomycin at 37°C in 5% CO~2~. The PD stock solution was prepared in 1% dimethylsulfoxide (DMSO) and diluted with culture medium immediately prior to the experiment. The cells were treated with H~2~O~2~ (400 *μ*M) \[[@B25]\] alone or in combination with PD for 4 h. After the treatments, the cells were prepared for further studies.

2.3. Analysis of Cell Viability and Morphology {#sec2.3}
----------------------------------------------

The viability of HUVECs was assessed using the MTT assay referring to a previous study \[[@B25]\]. Briefly, cells were seeded in 96-well plates. After being treated with H~2~O~2~ and PD of different concentrations for 4 h, the cells were washed for 3 times with PBS, then 100 *μ*L of MTT solution (0.5 mg/mL) was added directly to the culture medium, and the cells were incubated for 4 h at 37°C. After MTT removal, 100 *μ*L of N,N-dimethylformamide was added to each well to dissolve the formazan crystals, and the plates were shaken for 15 min at 37°C. Absorbance of samples was measured at 490 nm using a Microplate Reader (SpectraMax 190, Molecular Device, USA), and the results were expressed as % cell viability by the analysis of an OD value.

2.4. Cell Adhesion Assay {#sec2.4}
------------------------

Cell adhesion test was assessed as previously described \[[@B26]\]. After different treatments, cells (1 × 10^4^ cell per well) were resuspended in culture medium, placed on fibronectin-coated 6-well plates, and incubated for 30 min at 37°C. Then the cells were gently washed with PBS for 3 times. The adherent cells were counted by independent and blinded investigators. The results were expressed as the percentage of control.

2.5. Wound Healing Assay {#sec2.5}
------------------------

As previously described \[[@B27]\], HUVECs were seeded in 6-well plates and cultured for 24 h. Subsequently, we scratched confluent cell monolayers with a P200 pipette tip to make three parallel "wounds" in each well and washed the cells with serum-free medium. After the cells were incubated with different treatments for 8 h, the migrated cells were photographed using an inverted/phase-contrast microscopy (Olympus BX61, Japan). The mean distance between the two ends of the scratch was quantified by manual measurements.

2.6. Measurement of the Content of ROS {#sec2.6}
--------------------------------------

Measurement of intracellular ROS was based on ROS-mediated conversion of nonfluorescent 2′,7′-DCFH-DA into fluorescent DCFH, as previously described \[[@B25]\]. After being seeded and incubated with different treatments for 4 h in black 96-well plates, the cells were washed with PBS and subsequently incubated with DCFH-DA (20 microM) in PBS at 37°C for 2 h. At the end of incubation, the fluorescence of the cells was measured using an FLX 800 microplate fluorescence reader (the emission wavelength, 530 nm; the excitation wavelength, 485 nm) (Biotech Instruments Inc., USA). The background was from cell-free conditions. The results were expressed as the fold of the fluorescence intensity compared to the control group.

2.7. Measurement of LDH Release {#sec2.7}
-------------------------------

LDH release, which could reflect the cell membrane integrity, was detected with an assay kit (A020-1, Jiancheng, Nanjing, China) according to the manufacturer\'s instructions. Briefly, after incubation with different treatments for 4 h, the cells were centrifuged at 300 ×g for 10 min. Then 60 *μ*L supernatant was added with 30 *μ*L LDH substrate solution for incubation for 30 min at 37°C. The activity of enzyme was expressed as units per liter, and the absorbance was read at 440 nm.

2.8. Measurement of the Intracellular Contents of GSH-Px and SOD {#sec2.8}
----------------------------------------------------------------

Commercially available kits for the measurement of SOD (A001-3, Jiancheng, Nanjing) and GSH-Px (A061-2, Jiancheng, Nanjing, China) were used according to the manufacturer\'s instructions. After being lysed by the compound lysis buffer and centrifuged at 12000 r/mim for 5 min, the cell supernatant was collected for detecting the contents of GSH and SOD that were expressed as units/mg protein. One unit of SOD was equal to the amount that reduced the absorbance by a half at 550 nm. The GSH-Px activity assay was performed by quantifying the oxidation rate of reduced GSH to oxidized form by H~2~O~2~ and catalyzed by GSH-Px. One unit of GSH-Px was equal to the amount that reduced the level of GSH at 412 nm by 1 mM in one min per mg protein.

2.9. Cellular Apoptosis Assay {#sec2.9}
-----------------------------

The apoptosis of HUVECs was analyzed by performing a TUNEL assay using a commercial kit (11684817910, Roche Company, Germany) according to the manufacturer\'s instructions. After being fixed in paraformaldehyde (4%) for 24 h, the nuclei of the apoptotic cells were stained green, and all of the nuclei were stained blue with 4′,6-diamino-2-phenylindole (DAPI). The TUNEL positive ratio was expressed as the ratio of positively stained cells to the total number of HUVECs.

2.10. Measurement of Caspase-3 Activity {#sec2.10}
---------------------------------------

Apoptotic cell death was determined by caspase-3 activation via a fluorometric kit (G007, Jiancheng, Nanjing, China). Briefly, after being seeded and treated in 96-well plates, endothelial cells were harvested using caspase lysis buffers (50 mM HEPES, pH 7.4, 0.1% Chaps, 5 mM dithiothreitol, 0.1 mM EDTA, and 0.1% Triton X-100) for 5 min on ice and centrifuged at 12000 rpm for 10 min at 4°C. Then the supernatant (50 *μ*g) was saved and incubated with 10 *μ*L caspase-3 substrate (Ac-DEVDpNA) for 1 h at 37°C. The fluorescence emission was measured using a Biotech microplate fluorescence reader at an excitation wavelength of 400 nm (emission wavelength, 505 nm). The fluorescence intensity was set as 100% in the control group.

2.11. Western Blot Assay {#sec2.11}
------------------------

HUVECs were washed with PBS and lysed with 100 *μ*L RIPA Lysis buffer (Beyotime, Shanghai, China, P0013C) containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, and 0.1% SDS for 30 min on ice. Then cells were scraped and centrifuged for 10 min at 4°C and the concentration was qualified with a BCA protein Assay Kit (Lot\#PI208677, Thermo, Rochford, USA). Proteins of a total content of 50 *μ*g were separated on SDS-polyacrylamide gel electrophoresis gels (SDS-PAGE) and transferred to nitrocellulose membranes. The membranes were blocked with 5% nonfat milk and then incubated with primary antibodies (PKC *δ* and PKC *ε* with a dilution of 1 : 2000, PKC *α*, p-PKC *ε*, Bcl-2, Bax and GAPDH with a dilution of 1 : 1000, p-PKC *α*/*β* with a dilution of 1 : 300, and p-PKC *δ* with a dilution of 1 : 100) and horseradish peroxidase-conjugated secondary antibody (Zhongshan Jinqiao, Beijing). The blot was developed with a Supersignal Chemiluminescence detection kit (Solarbio, Beijing) and observed with ChemiDoc XRS+ Molecular Imager (BIO-RAD).

2.12. Statistical Analysis {#sec2.12}
--------------------------

All values in the text and figures are presented as mean ± SEM of at least three independent experiments. Analysis of variance of parametric difference among experimental data was performed by one-way ANOVA and Dunnett\'s test was then performed for multiple comparisons \[[@B16]\]. Western blot densities were analyzed with Kruskal-Wallis ANOVA test \[[@B28]\]. Values of *p* \< 0.05 were considered statistically significant.

3. Results {#sec3}
==========

3.1. Effects of PD on the Cell Viability, Adhesive Ability, and Migratory Ability of OS-Injured HUVECs {#sec3.1}
------------------------------------------------------------------------------------------------------

To investigate whether PD could prevent endothelium from OSI, HUVECs were subjected to H~2~O~2~ (400 *μ*M) in the absence or presence of PD of various concentrations (0.1--10 *μ*g/mL) for 4 hours. The cell viability decreased to 48% after H~2~O~2~ treatment. Although the difference between H~2~O~2~ group and the low dose group (0.1 *μ*g/mL) was not manifest, the cell viability elevated to 72% when the concentration of PD was 3 *μ*g/mL or higher ([Figure 1(a)](#fig1){ref-type="fig"}). Based on these results, treatment with 400 *μ*M H~2~O~2~ and 3 *μ*g/mL PD for 4 hours was selected for the further experiments. As shown in [Figure 1(b)](#fig1){ref-type="fig"}, H~2~O~2~ treatment resulted in the change of cell morphology, such as remarkable cell shrinkage and reduced refraction. Meanwhile, the cellular adhesion rate in the H~2~O~2~ group was reduced by more than 50% compared to the control group. The PD treatment significantly improved the cellular adhesion rate but the cell shape did not evidently recover compared to the H~2~O~2~ group. As demonstrated in [Figure 1(c)](#fig1){ref-type="fig"}, the distance between the scratches increased significantly after treatment with H~2~O~2~ compared to the control group but curtailed almost 40% after PD treatment compared to the H~2~O~2~ group, indicating that PD enhanced the migratory ability of HUVECs injured by H~2~O~2~.

3.2. Effects of PD on LDH, ROS, GSH-Px, and SOD Measured in OS-Injured HUVECs {#sec3.2}
-----------------------------------------------------------------------------

To explore the effects of PD on the oxidative stress of H~2~O~2~-injured HUVECs, we next measured the levels of intracellular LDH, ROS, GSH-Px, and SOD. H~2~O~2~ treatment elevated the level of LDH to 5 times ([Figure 2(a)](#fig2){ref-type="fig"}), doubled ROS release ([Figure 2(b)](#fig2){ref-type="fig"}), and reduced the content of GSH-Px and SOD by a half (Figures [2(c)](#fig2){ref-type="fig"} and [2(d)](#fig2){ref-type="fig"}) compared to the control group. However, PD replenishment induced a remarkable decrease in the level of LDH by more than 50% ([Figure 2(a)](#fig2){ref-type="fig"}) and ROS by 18% and significantly attenuated the changes in the content of GSH-Px by 33% ([Figure 2(c)](#fig2){ref-type="fig"}) and SOD by 60% ([Figure 2(d)](#fig2){ref-type="fig"}) compared to the H~2~O~2~ group, indicating the protective activity of PD.

3.3. Effects of PD and THX on the Apoptosis of OS-Injured HUVECs {#sec3.3}
----------------------------------------------------------------

The antiapoptotic effect of PD has been demonstrated in previous studies \[[@B11], [@B12]\]. We therefore explored whether PD could attenuate the apoptosis of H~2~O~2~-injured HUVECs and the possible involvement of PKC signaling. As shown in [Figure 3(a)](#fig3){ref-type="fig"}, the TUNEL positive ratio increased from less than 1% to 50% after H~2~O~2~ treatment and decreased to 25% when PD was replenished. Furthermore, the activity of caspase-3 increased by 200% after H~2~O~2~ treatment compared to the control group and decreased by almost 30% when PD was added ([Figure 3(b)](#fig3){ref-type="fig"}). Nonetheless, after the forced activation of PKC by THX (100 nM) \[[@B29]\], the apoptosis ratio and caspase-3 activity increased to a degree even higher than those of the H~2~O~2~-treated group (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). In line with this observation, the attenuated expression of proapoptotic molecule Bax and the corresponding enhanced expression of antiapoptotic signal Bcl-2 were noticeable when the cells were treated with H~2~O~2~ and PD compared to the H~2~O~2~ group, whereas THX treatment suppressed the effects of PD on Bax and Bcl-2 expression ([Figure 3(c)](#fig3){ref-type="fig"}).

3.4. Effects of PD on Phosphorylation Level of PKC in OS-Injured HUVECs {#sec3.4}
-----------------------------------------------------------------------

Our above data collectively raise the possibility that PD may exert its antiapoptotic effect on endothelial cells through PKC dependent pathway. Since PKC *α* and PKC *δ* have been reported to be activated by oxidative stress \[[@B30]\] and PKC *ε* is an important molecule in the protection of OSI \[[@B24]\], we determined whether PD attenuates OSI in HUVECs through regulation of these three PKCs. As shown in the left panel of [Figure 4](#fig4){ref-type="fig"}, HUVECs expressed all the three isoforms of PKC. No obvious differences in the total amount of PKCs *α*, *δ*, and *ε* were observed among the three groups as indicated in the left panel. It is worth noting that the level of proteolytic fragment of PKC *δ* (41 kDa) significantly increased along with H~2~O~2~ stimulation (\<0.01) but abated remarkably after PD incubation (\<0.05). A ratio of phospho-PKC to the total PKC was calculated to evaluate the activation of PKC upon stimulation to oxidative stress (the right panel of [Figure 4](#fig4){ref-type="fig"}). An increased phosphorylation level of both PKC *α* (by 65%) and PKC *δ* (by 100%) was observed after H~2~O~2~ treatment, while PD replenishment was able to decrease the phosphorylation level of PKC *α* (by 17.6%) and PKC *δ* (by 42.8%) compared to the H~2~O~2~ group. As to the content of p-PKC *ε*, little difference was found between the control group and H~2~O~2~ single treated group (\>0.05). But compared with H~2~O~2~ group, the level of p-PKC *ε* was increased by 50.5% after being treated in combination with PD compared to H~2~O~2~ single treated group.

4. Discussion {#sec4}
=============

It is well documented that endothelial dysfunction is a crucial event in the development of CVDs including atherosclerosis, myocardial ischemia reperfusion, and hypertension. The endothelial cells are very sensitive to OSI, which is involved in endothelial dysfunction \[[@B32]\]. In the present study, we established H~2~O~2~-induced OSI model to study the protective effect of PD against endothelial damage. We confirmed that PD conferred protection to HUVECs against H~2~O~2~ by improving cell viability and adhesive and migratory abilities. These findings concur with previous studies where resveratrol, the deglycosylation form of PD, significantly attenuates the decrease of cell viability in OS injured HUVECs \[[@B33]\] and the methamphetamine-induced neurotoxicity in mouse mesencephalic neurons \[[@B13]\] and evidently enhance activities of proliferation, adhesion, and migration of endothelial progenitor cells \[[@B34]\]. Thus, our results suggest that supplementation with PD could ameliorate endothelial dysfunction induced by OSI.

Oxidative stress results from an imbalance between oxidants and antioxidants within cells \[[@B4]\]; namely, the enhanced ROS overwhelms the antioxidative capacity and subsequently leads to endothelial dysfunction \[[@B35]\]. GSH-Px, SOD, and other enzymatic and nonenzymatic antioxidants play pivotal roles in preventing the cellular damage caused by ROS. In the present study, an obvious elevation of LDH and ROS production along with significant decrease in GSH-Px as well as SOD was observed in HUVECs after subjected to H~2~O~2~, indicating the shift of the balance between oxidative systems and antioxidant defenses. Nonetheless, when HUVECs were supplied with PD, the changes of these indexes induced by H~2~O~2~ were partially reversed. This is in agreement with previous reports confirming that administration of PD significantly limits LDH release from the I/R infracted myocardial tissue \[[@B14]\] and elevates the activity of SOD in I/R injured lung \[[@B10]\]. Similarly, PD has also been reported to exert antioxidative activity in kidney \[[@B8]\] and brain \[[@B9]\] as indicated before. These results clearly suggest that PD is a potent antioxidant against OSI related diseases.

Given that PD has antiapoptotic abilities \[[@B36], [@B37]\], we confirmed these findings of the change of several apoptosis related indexes including TUNEL staining positive ratio, caspase-3 activity, and Bax and Bcl-2 levels. Here, we found that the treatment with PD could significantly restrain H~2~O~2~-induced apoptosis, as verified by the reduction of TUNEL positive ratio, the caspase-3 activity, and Bax expression as well as by the upregulation of Bcl-2 expression. There is abundant evidence to support that PKC signaling plays a crucial role in OSI events. For instance, PKC is activated in redox stress in cardiac muscle cells \[[@B38]\] and endothelial cells \[[@B39]\]. As expected, the aforementioned antiapoptotic effect of PD vanished after PKC consistent activation by THX. Collectively, these results indicated that forced activation of PKC signaling could abolish the antiapoptotic effects of PD under oxidative stress condition. Our study demonstrated for the first time that PD may suppress apoptosis in H~2~O~2~-injured HUVECs through inhibiting PKC signaling pathway. These findings are in line with other studies, in which PD exerts protective effects against myocardial I/R and pulmonary hypertension through interaction with PKC signaling \[[@B14], [@B15]\].

Among PKC isoforms, PKCs *α*, *β*, *δ*, and *ε* are mainly involved in the pathogenesis of CVDs \[[@B20]\]. In the present study, conventional isoform *α*, novel isoforms *δ* and *ε*, and their phosphorylation were examined in HUVECs. PKC *α* has been validated to enhance superoxide production via NADPH oxidase \[[@B40]\] and to be activated by reactive oxygen species production in endothelial cells, which in turn activated the apoptosis pathway \[[@B41]\]. Upon activation, PKC *δ* mediates oxidative stress and cell death in a dietary model of nonalcoholic steatohepatitis \[[@B22]\] and in endothelia cells of lungs \[[@B46]\]. It is of special interest to investigate whether PD attenuates OSI in HUVECs through inhibition of PKCs *α* and *δ* cellular circuit. Our observation of significant phosphorylation of PKCs *α* and *δ* in HUVECs after exposure to H~2~O~2~ is consistent with the previous results obtained in COS-7 cells \[[@B30]\].

Meanwhile, as our results showed, the phosphorylation of PKCs *α* and *δ* decreased with PD replenishment. Interestingly, an enhanced 41 kDa proteolytic fragment below the total PKC *δ* protein band appeared when the cells were subjected to H~2~O~2~. This proteolytic fragment is probably caused by the elevated caspase-3 activity during H~2~O~2~ stimulation, which is consistent with other articles showing that caspase-3 cleaves the native PKC *δ* into a 41 kDa catalytically active fragment and a 38 kDa regulatory fragment to keep activating the kinase \[[@B43], [@B44]\]. The cleavage fragment has high catalytic activity and plays a key role in promoting apoptotic cell death. Thus, attenuation of PKC *δ* proteolytic activation may be also involved in the antiapoptotic effect of PD.

PKC *ε*, another member of novel PKC subfamily, is highly homologous to PKC *δ*. However, PKC *ε* and PKC *δ* sometimes have opposite effects. For example, PKC *ε* activation involved in isoflurane pretreatment could activate downstream signaling pathways and exert cardioprotection, which is directly opposed to that of PKC *δ* \[[@B24]\]. As shown in our results, there was little difference in PKC *ε* phosphorylation between the control group and H~2~O~2~-treated group, but the p-PKC *ε* significantly increased after being treated with PD. Similarly, previous research has shown that decrease in the apoptosis of cardiocytes damaged by H~2~O~2~ is partially attributed to the increased p-PKC *ε* \[[@B45]\]. Altogether, these studies reveal that PD protects H~2~O~2~-induced OSI through activation of PKC *ε*.

5. Conclusions {#sec5}
==============

In summary, the present study demonstrates that PD could prevent HUVECs from H~2~O~2~-induced OSI, as evidenced by improvements of cell viability, adhesive and migratory ability, the rebalance between intracellular oxidants and antioxidants, and the inhibition of apoptosis. Nevertheless, the protective effects of PD are totally reversed when PKC signaling is compulsively activated by THX. Moreover, the phosphorylation of PKCs *α* and *δ* significantly decreases while the phosphorylation of PKC *ε* conspicuously increases after PD replenishment. Hence, PD may exert its antioxidative stress effects on H~2~O~2~-injured HUVECs through PKC dependent pathway.
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![Effects of PD on the viability, adhesive ability, and migratory ability of OS-injured HUVECs. (a) HUVECs were subjected to H~2~O~2~ (400 *μ*M) in the absence or presence of PD of different concentrations for 4 hours. The cell viability of HUVECs was measured by the MTT assay. (b) The adhesive ability of the HUVECs was assessed by performing an adhesion assay, and cell adhesion was expressed as an adhesion ratio. The number of adherent cells in the control group was set at 100%. The cell morphology was observed using inverted/phase-contrast microscopy, and images were obtained. (c) The migratory ability of the HUVECs was assessed by performing a wound healing assay, and the migratory ability was expressed as the mean distance between the two ends of the scratch. The mean distance in the control group was set at 100%. The results are expressed as mean ± SEM, *n* = 3 (^*∗∗*^ *p* \< 0.01, compared to the control group, ^\#^ *p* \< 0.05, ^\#\#^ *p* \< 0.01, compared to the H~2~O~2~ group). Significant differences between groups were analyzed with one-way ANOVA.](OMCL2016-5139458.001){#fig1}

![Effects of PD on LDH, ROS, GSH-Px, and SOD in OS-injured HUVECs. HUVECs were treated with H~2~O~2~ (400 *μ*M) alone or with PD (3 *μ*g/mL). (a) The release of LDH from HUVECs was detected using an assay kit. (b) The intensity of DCFH fluorescence was measured to evaluate the intracellular ROS level. (c) The intracellular GSH-Px level of HUVECs. (d) The intracellular SOD level of HUVECs. The results are expressed as mean ± SEM, *n* = 3 (^*∗∗*^ *p* \< 0.01, compared to control group, ^\#^ *p* \< 0.05, ^\#\#^ *p* \< 0.01, compared to H~2~O~2~ group). Significant differences between groups were analyzed with one-way ANOVA.](OMCL2016-5139458.002){#fig2}

![Effects of PD and THX on the apoptosis of OS-injured HUVECs. (a) The apoptosis of the HUVECs was assessed by the TUNEL assay. TUNEL staining was performed to stain the nuclei of the apoptotic cells (green), and DAPI was used to stain all of the nuclei (blue). The apoptotic index was expressed as the percentage of positively stained apoptotic cells out of the total number of cells counted. (b) The caspase-3 activity was measured via a fluorometric kit. (c) The Western blots images of Bcl-2 and Bax are, respectively, shown in the upper panel. The lower panels represent the densitometric analysis of the data. GAPDH was used as a loading control. The results are expressed as mean ± SEM, *n* = 3 (^*∗*^ *p* \< 0.05, ^*∗∗*^ *p* \< 0.01). Significant differences between groups were analyzed with one-way ANOVA.](OMCL2016-5139458.003){#fig3}

![Effects of PD on the levels of p-PKC *δ* of OS-injured HUVECs. The Western blots images of p-PKC *α*, p-PKC *δ*, p-PKC *ε*, and total PKCs *α*, *δ*, and *ε* are shown in the left panel. The right panel represents the densitometric analysis of the data. Expression of each p-PKC was normalized to total PKC content, and GAPDH was used as a loading control. The result are expressed as mean ± SEM, *n* = 3 (^*∗∗*^ *p* \< 0.01, compared to the control group, ^\#^ *p* \< 0.05, ^\#\#^ *p* \< 0.01, compared to the H~2~O~2~ group). Significant differences between groups were analyzed with one-way ANOVA.](OMCL2016-5139458.004){#fig4}
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